Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Mar 10

PMID 35269952

Authors

Alexandre Vallee

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a very complex syndrome involving widespread brain multi-dysconnectivity. Schizophrenia is marked by cognitive, behavioral, and emotional dysregulations. Recent studies suggest that inflammation in the central nervous system (CNS) and immune dysfunction could have a role in the pathogenesis of schizophrenia. This hypothesis is supported by immunogenetic evidence, and a higher incidence rate of autoimmune diseases in patients with schizophrenia. The dysregulation of the WNT/β-catenin pathway is associated with the involvement of neuroinflammation in schizophrenia. Several studies have shown that there is a vicious and positive interplay operating between neuroinflammation and oxidative stress. This interplay is modulated by WNT/β-catenin, which interacts with the NF-kB pathway; inflammatory factors (including IL-6, IL-8, TNF-α); factors of oxidative stress such as glutamate; and dopamine. Neuroinflammation is associated with increased levels of PPARγ. In schizophrenia, the expression of PPAR-γ is increased, whereas the WNT/β-catenin pathway and PPARα are downregulated. This suggests that a metabolic-inflammatory imbalance occurs in this disorder. Thus, this research's triptych could be a novel therapeutic approach to counteract both neuroinflammation and oxidative stress in schizophrenia.

Citing Articles

Increased risk of chronic diseases and multimorbidity in middle-aged and elderly individuals with early vision, hearing, or dual sensory impairments: insights from prospective cohort studies and Mendelian randomization analysis.

Wang Y, Cheng F, Hou N, Tan Y, Zhang S, Hou Y BMC Med. 2025; 23(1):118.

PMID: 40001102 PMC: 11863693. DOI: 10.1186/s12916-025-03857-x.

Protective effects of sesamol against cigarette smoke toxicity on the blood-brain barrier.

Koru I, Atasever-Arslan B BMC Complement Med Ther. 2025; 25(1):68.

PMID: 39987119 PMC: 11846467. DOI: 10.1186/s12906-025-04796-z.

Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia.

Yee J, Phua S, See Y, Andiappan A, Goh W, Lee J Transl Psychiatry. 2025; 15(1):51.

PMID: 39952924 PMC: 11828904. DOI: 10.1038/s41398-025-03264-z.

Molecular and Functional Analysis of TLR 1, 2 and 6 in Peripheral Blood Monocytes of Patients with Schizophrenia: A Pilot Study.

Sotelo-Ramirez C, Valdes-Tovar M, Zaragoza-Hoyos J, Ortiz-Lopez L, Argueta J, Rosel-Vales M Int J Mol Sci. 2025; 26(3).

PMID: 39940697 PMC: 11817014. DOI: 10.3390/ijms26030926.

The Role of Neuroglia in the Development and Progression of Schizophrenia.

Rawani N, Chan A, Todd K, Baker G, Dursun S Biomolecules. 2025; 15(1).

PMID: 39858403 PMC: 11761573. DOI: 10.3390/biom15010010.

References

Murphy C, Walker A, Weickert C . Neuroinflammation in schizophrenia: the role of nuclear factor kappa B. Transl Psychiatry. 2021; 11(1):528. PMC: 8516884. DOI: 10.1038/s41398-021-01607-0. View

Hoeflich K, Luo J, Rubie E, Tsao M, Jin O, Woodgett J . Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 2000; 406(6791):86-90. DOI: 10.1038/35017574. View

Lutgen V, Narasipura S, Sharma A, Min S, Al-Harthi L . β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes. J Neuroinflammation. 2016; 13(1):242. PMC: 5018172. DOI: 10.1186/s12974-016-0691-7. View

Lu D, Carson D . Repression of beta-catenin signaling by PPAR gamma ligands. Eur J Pharmacol. 2010; 636(1-3):198-202. PMC: 2866743. DOI: 10.1016/j.ejphar.2010.03.010. View

Stefansson H, Ophoff R, Steinberg S, Andreassen O, Cichon S, Rujescu D . Common variants conferring risk of schizophrenia. Nature. 2009; 460(7256):744-7. PMC: 3077530. DOI: 10.1038/nature08186. View

De Ferrari G, Avila M, Medina M, Perez-Palma E, Bustos B, Alarcon M . Wnt/β-catenin signaling in Alzheimer's disease. CNS Neurol Disord Drug Targets. 2013; 13(5):745-54. DOI: 10.2174/1871527312666131223113900. View

Rosi M, Luccarini I, Grossi C, Fiorentini A, Spillantini M, Prisco A . Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J Neurochem. 2010; 112(6):1539-51. DOI: 10.1111/j.1471-4159.2009.06566.x. View

Turillazzi E, Neri M, Cerretani D, Cantatore S, Frati P, Moltoni L . Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kB. J Cell Mol Med. 2016; 20(4):601-12. PMC: 5125979. DOI: 10.1111/jcmm.12748. View

Kawai T, Akira S . Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007; 13(11):460-9. DOI: 10.1016/j.molmed.2007.09.002. View

10.

Hur E, Zhou F . GSK3 signalling in neural development. Nat Rev Neurosci. 2010; 11(8):539-51. PMC: 3533361. DOI: 10.1038/nrn2870. View

11.

Jiang B, Wang Y, Wang H, Song L, Huang C, Zhu Q . Antidepressant-like effects of fenofibrate in mice via the hippocampal brain-derived neurotrophic factor signalling pathway. Br J Pharmacol. 2016; 174(2):177-194. PMC: 5192965. DOI: 10.1111/bph.13668. View

12.

Winston J, Strack P, Chu C, Elledge S, Harper J . The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999; 13(3):270-83. PMC: 316433. DOI: 10.1101/gad.13.3.270. View

13.

Inestrosa N, Varela-Nallar L . Wnt signaling in the nervous system and in Alzheimer's disease. J Mol Cell Biol. 2014; 6(1):64-74. DOI: 10.1093/jmcb/mjt051. View

14.

Najjar S, Pearlman D . Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res. 2014; 161(1):102-12. DOI: 10.1016/j.schres.2014.04.041. View

15.

Baxter P, Bell K, Hasel P, Kaindl A, Fricker M, Thomson D . Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system. Nat Commun. 2015; 6:6761. PMC: 4403319. DOI: 10.1038/ncomms7761. View

16.

Eid T, Tu N, Lee T, Lai J . Regulation of astrocyte glutamine synthetase in epilepsy. Neurochem Int. 2013; 63(7):670-81. PMC: 3825815. DOI: 10.1016/j.neuint.2013.06.008. View

17.

Wang A, Miller B . Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression. Schizophr Bull. 2017; 44(1):75-83. PMC: 5768046. DOI: 10.1093/schbul/sbx035. View

18.

Muller N, Weidinger E, Leitner B, Schwarz M . The role of inflammation in schizophrenia. Front Neurosci. 2015; 9:372. PMC: 4612505. DOI: 10.3389/fnins.2015.00372. View

19.

Vallee A, Lecarpentier Y, Vallee J . Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway. Mol Psychiatry. 2021; 27(1):230-248. DOI: 10.1038/s41380-021-01086-1. View

20.

Vallee A, Lecarpentier Y, Guillevin R, Vallee J . Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease. Acta Biochim Biophys Sin (Shanghai). 2017; 49(10):853-866. DOI: 10.1093/abbs/gmx073. View